Alcon is a global eye care company that develops and sells surgical devices, implants, and consumables for cataract, vitreoretinal, refractive, and glaucoma procedures, as well as a comprehensive range of vision care products including contact lenses, artificial tears, dry eye treatments, and ocular health solutions. The company generates revenue through direct sales of these products to surgeons, ophthalmic surgical centers, eye care professionals, optometrists, healthcare systems, hospitals, and retail distributors worldwide. Alcon maintains profitability through its diversified product portfolio combining established products with ongoing innovation, geographic market diversification, and operational efficiency from its transformation program, while investing in research and development to develop new treatments for unmet eye care needs.